Partnership between Persei vivarium and the Colombian Crohn and Colitis Study Group (GECCOL) to develop high-impact Digital Health projects in Colombia
Our company, Persei vivarium, has been working hand in hand with the Colombian Crohn and Colitis Study Group (GECCOL). We have signed a partnership agreement to develop high-impact Digital Health projects focused on Inflammatory Bowel Disease in Colombia.
Persei vivarium participates in the ECCO’23 Congress, the landmark event for Inflammatory Bowel Disease, thanks to the UR-CARE project
Our company participated once again in the 18th Congress of ECCO that took place March 1-4 in Copenhagen, due to the UR-CARE project (United Registries for Clinical Assessment platform). We attended meetings, shared information about the project, and encouraged the participation of new users.
International Women’s Day 2023: For an inclusive digital world
On March 8th, Persei vivarium will again celebrate International Women’s Day, with this year’s theme from UN Women: “DigitALL: Innovation and technology for gender equality”. On the pathway to achieving real equality between women and men, access to digital education is key to encouraging the inclusion of women and girls in technology fields.
Where is the Digital Therapeutics (DTx) market headed?
Digital Therapeutics (DTx) are occupying a prominent place in the Digital Health environment, given that they present effective solutions, based on scientific evidence, for the effective management of diseases and the active participation of patients in their diseases. As a result, healthcare professionals and the industry have a growing desire to implement them.
More than 4.000 patients, 90 centers, and 15 publications about COVID-19 in pregnant women confirm the value of the ObsCOVID Registry, implemented with Persei vivarium technology
The Spanish ObsCOVID Registry was launched in 2020, with the goal of determining the effects of COVID on pregnant women and newborns, and improving care for pregnant women through a set of appropriate measures.
The promising sector of Digital Therapeutics (DTx)
Digital Therapeutics are software based on scientific evidence, aimed at preventing, managing, and treating diseases. The goal of these tools is to improve health outcomes in patients as well as decision-making by healthcare professionals. They are distinguished from other Digital Health tools in that they are evaluated and approved by regulatory entities.